Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-04-30A Phase II Trial Of Bryostatin-1 In Combination With Rituximab In Rituximab-Refractory Indolent B-cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2015-04-29A Phase I Trial of Oral Perifosine With Different Loading Schedules in Patients With Refractory Neoplasms
-
CLINICAL_TRIALS study record update · 2015-04-29Phase I and Pharmacokinetic Study of UCN-01 and Fludarabine in Relapsed or Refractory Low-Grade Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2015-04-29Phase I Trial and Pharmacokinetic Study of Arsenic Trioxide in Pediatric Patients With Refractory Leukemia or Lymphoma
-
CLINICAL_TRIALS study record update · 2015-04-29PHASE I STUDY OF ANTI-TAC(Fv)-PE38 (LMB-2), A RECOMBINANT SINGLE-CHAIN IMMUNOTOXIN FOR TREATMENT OF TAC-EXPRESSING MALIGNANCIES
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-04-29Phase I Study of BL22, a Recombinant Immunotoxin for Treatment of CD22+ Leukemias and Lymphomas
-
CLINICAL_TRIALS study record update · 2015-04-28A Pilot Study of Phenylbutyrate, Dexamethasone and GM-CSF in Refractory or Relapsed t(8;21) Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2015-04-28Phase I Study of Recombinant BL22 Immunotoxin in Patients With CD22-Positive B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2015-04-28PHASE I STUDY OF T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA USING THE MIK-BETA 1 MONOCLONAL ANTIBODY DIRECTED TOWARD THE IL-2R BETA SUBUNIT
-
CLINICAL_TRIALS study record update · 2015-04-15Unrelated Donor Stem Cell Transplant for Patients With Malignant and Non-Malignant Disorders
-
CLINICAL_TRIALS study record update · 2015-04-14Phase II Study of Pegylated Ifná-2a (Pegasys) in Patients With Chronic Myeloid Leukemia Who Have Minimal Residual Disease While Receiving Therapy With Tyrosine Kinase Inhibitors
-
CLINICAL_TRIALS study record update · 2015-04-08Acupuncture for Mucositis Pain in Cancer Care
-
CLINICAL_TRIALS study record update · 2015-04-07Clinical Study of Granulocyte Colony-stimulating Factor (G-CSF)-Primed, Peripheral-blood Progenitor Cells for the Prevention of Relapse Advanced Stage Leukemia
-
CLINICAL_TRIALS study record update · 2015-03-25Phase I Study of CL-F-ARA-A in Solid and Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2015-03-23An Open Label Phase II Trial of Clofarabine and Temsirolimus in Older Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2015-03-12A Phase I Trial Of Sirolimus In Relapsed/Refractory Leukemia And Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2015-03-06A Phase II Study of Gemtuzumab Ozogamicin (Mylotarg) and Standard Dose ARA-C for Patients With Relapsed Acute Myeloid Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2015-03-06S9910, Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
-
CLINICAL_TRIALS study record update · 2015-03-06A Phase II Study of Daunomycin and ARA-C Given by Continuous IV Infusion With PSC-833 for Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) in Patients of Age 56 or Older
-
CLINICAL_TRIALS study record update · 2015-03-06A PHASE I/II STUDY OF RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH METHOTREXATE (MTX) AND CYCLOSPORINE (CPS) IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FROM RELATED DONORS MISMATCHED FOR ONE HLA ANTIGEN IN THE DIRECTION OF GRAFT-VERSUS-HOST DISEASE (GVHD)
-
CLINICAL_TRIALS study record update · 2015-03-06A Phase III Randomized Study Comparing Busulfan-Total Body Irradiation Versus Cyclophosphamide-Total Body Irradiation Preparative Regimen in Patients With Advanced Myelodysplastic Syndrome (MDS) or MDS-Related Acute Myeloid Leukemia (AML) Undergoing HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation, (A BMT Study)
-
CLINICAL_TRIALS study record update · 2015-03-06S0106B, Stem Cell Origin in AML: Prognostic and Therapeutic Implications
-
CLINICAL_TRIALS study record update · 2015-03-06Determining the Clinicopathological Significance of CaMKIIgamma Activation in AML
-
CLINICAL_TRIALS study record update · 2015-03-06A Phase II Study Of Daunomycin And ARA-C, Both Given By Continous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older
-
CLINICAL_TRIALS study record update · 2015-03-06Topoisomerase 2 Expression and Acute Myeloid Leukemia (AML)